2nd Quarter - Report

HEALTH AND MEDICINE COUNSEL for NEPHURE

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Research in Kidney Disease FDA drug development H.R. 2969: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011

LobbyistCovered position, as disclosed
SARAH BUCHANAN Legislative Consultant
DALE P DIRKS Legislative Consultant

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Bills named: H.R. 2969 (113th)

Budget/Appropriations BUD

FY14 L-HHS FY14 MilCon-VA FY14 Defense

LobbyistCovered position, as disclosed
SARAH BUCHANAN Legislative Consultant
DALE P DIRKS Legislative Consultant

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.